"...or the failure of the company to be identified
Post# of 36552
(Total Views: 441)
Posted On: 02/14/2022 2:55:47 PM
"...or the failure of the company to be identified on biotech information sources as company in progress on vaccine development."
Please see the NYT Covid-19 Vaccine Tracker:
https://www.nytimes.com/interactive/2020/scie...acker.html
and look under:
PRECLINICAL
"Other protein-based vaccines"
and you'll see Generex is still identified as a company still in progress on vaccine development.
Updated February 11th, 2022
If they had abandoned their research then they would show up on this website as "ABANDONED"
Please see the NYT Covid-19 Vaccine Tracker:
https://www.nytimes.com/interactive/2020/scie...acker.html
and look under:
PRECLINICAL
"Other protein-based vaccines"
and you'll see Generex is still identified as a company still in progress on vaccine development.
Updated February 11th, 2022
If they had abandoned their research then they would show up on this website as "ABANDONED"
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼